Pacific Biosciences of California, Inc. (PACB) News
Filter PACB News Items
PACB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PACB News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest PACB News From Around the Web
Below are the latest news stories about PACIFIC BIOSCIENCES OF CALIFORNIA INC that investors may wish to consider to help them evaluate PACB as an investment opportunity.
PACB Stock Rises After the Shipment of Vega Systems to Berry GenomicsPacBio delivers the first Vega systems to Berry Genomics to develop and optimize its targeted assays to support screening programs in China and other markets. |
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi SequencingMENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human gut health test powered by Intus Bio’s groundbreaking Titan-1 platform and PacBio’s HiFi sequencing technology. By combining Intus Bio’s patented strain-level resolution assay and AI-powered analysis with PacBio’s renowned sequencing accuracy, GutI |
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian MarketsBerry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countriesMENLO PARK, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022. Under the terms of the original agreement, Berry Genomics will develop and optimize its targeted assays to supp |
Why the Market Dipped But Pacific Biosciences of California (PACB) Gained TodayPacific Biosciences of California (PACB) closed at $2 in the latest trading session, marking a +0.5% move from the prior day. |
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtWith Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025. |
PacBio to Present at 43rd Annual J.P. Morgan Healthcare ConferenceMENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for |
Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In?We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against the other CRISPR stocks. The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, […] |
Reasons to Retain PacBio Stock in Your Portfolio for NowPACB continues to deliver growth from its unique technologies amid business seasonality concerns. |
Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short SellersWe recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against other worst ARK stocks to buy according to short sellers. Cathie Wood of ARK Investment is one of Wall Street’s most […] |
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right NowWe recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in […] |